CIK 0001856725
- Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 863114789
- Phone
- +1 408-457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- 4 Open-market buy 10% owner bought 17,968 shares at an average $5.67 ($101,917)
- 4 Open-market buy 10% owner bought 19,250 shares at an average $5.23 ($100,612)
- 4 Open-market buy 10% owner bought 17,200 shares at an average $5.97 ($102,761)
- 4 Open-market buy 10% owner bought 8,400 shares at $6.03 ($50,617)
- 4 Open-market buy 10% owner bought 9,157 shares at $5.58 ($51,057)
- 4 Open-market buy 10% owner bought 13,300 shares at an average $7.59 ($100,973)
- 4 Open-market buy 10% owner bought 13,527 shares at an average $7.98 ($107,981)
- 4 Open-market buy 10% owner bought 24,550 shares at an average $8.12 ($199,440)
- 4 Open-market buy 10% owner bought 24,540 shares at an average $7.97 ($195,695)
- 4 Open-market buy 10% owner bought 13,100 shares at an average $7.47 ($97,879)
- 4 Open-market buy 10% owner bought 22,014 shares at an average $8.05 ($177,312)
- 4 Open-market buy 10% owner bought 8,202 shares at an average $7.93 ($65,040)
- 4 Open-market buy 10% owner bought 3,720 shares at $7.95 ($29,587)
- 4 Open-market buy 10% owner bought 4,196 shares at an average $7.84 ($32,898)
- 4 Open-market buy 10% owner bought 29,000 shares at an average $7.46 ($216,401)
- 4/A Open-market buy 10% owner bought 45,488 shares at an average $6.21 ($282,466)
- 4 Open-market buy 10% owner bought 15,192 shares at $6.90 ($104,794)
- 4 Open-market buy 10% owner bought 45,488 shares at an average $6.21 ($282,466)
- 4 Shares withheld for taxes Chief Financial Officer gave up 18,362 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 20,334 shares (to pay taxes)
Page 7 of 10 · 194 filings